InvestorsHub Logo
Followers 43
Posts 3008
Boards Moderated 0
Alias Born 09/23/2013

Re: speedo94947 post# 5587

Friday, 04/30/2021 10:37:11 AM

Friday, April 30, 2021 10:37:11 AM

Post# of 6002
Great news! RAFA will be a worldwide conglomerate. Adding another project to the list:

Rafarma is actively involved in the process of establishing contractual partnerships with approximately 200 companies in various countries, to be finalized by the summer of 2022.

>These include the USA, the EU and the ASEAN countries, China, Japan, Singapore, South Africa and Russia. Contractual partnerships have already been finalized with several companies in China, Uzbekistan, Czech Republic, Singapore, Malaysia and Russia.

Current R & D Projects:

Location: Haifa, Israel, 2021, Joint Venture with the Matam Technopark in Haifa, Israel
-Exosome research for pharmaceutical production and use, as well as joint research toward an artificially-created, modified bacterium to form a therapeutic platform for new drug designs.

Location: Uzbekistan, 2021, Joint Venture with Health Department of Uzbekistan
-Projected costs are currently at $82,000,000
-Construction started in Early 2021.
See the construction here:


Location: Moscow, 2021, Self-funded
Construction of site for contact production of adenovirus vector

Location: Batan - Indonesia, 2021-2023, Self-funded + bond loan
Construction of a plant and laboratories in Indonesia

Location: Krasnoyarsk-Russia, Czech Republic, 2021-25, Self-funded
Construction of production sites for sterile preparations

Location: Yver Region - Russia, 2021, Self-funded + bank loans
Construction of production sites for non-sterile drugs

Location: Dubna - Moscow Region, 2020-21, Self-funded
Reconstruction of an enterprise for radioopharmaceuticals

Location: Krasnoyarsk-Russia, 2020-21, Self-funded
Reconstruction of the R & D lab

Location: Istanbul-Turkey, 2021-25
Istanbul nuclear medicine center project

Location: Pereslavi-Russia, 2021-23
Nuclear medicine center near Moscow

Location: New York - USA, 2021-22
Construction of a laboratory on artificial immunity technologies in the suburbs of New York

Location: Kumertau-Bashkiria, Pereslavi-Yaroslavl region 2021-24
Reconstruction/construction of biotechnological production centers in the Czech Republic, Yaroslavi region, Bashkiria